← All stocks

Imunon, Inc.

IMNN Net buying
CIK 0000749647 #5285 in the set updated 17 Sep 2026
Bought (120 mo)
$490.39K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$38.15K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$38.15K
6 of 6 sales
Net
+$452.24K
+$452.24K against sales at will

By person

16 insiders · 46 transactions
0.2×

Stacy Lindborg holds only 0.2 times base salary in stock. $166.38K of shares against $568.14K in salary for 2025.

Salary from the company's own proxy. The shares are what Stacy Lindborg last reported holding, valued at $1.56, the price Common Stock was last bought or sold at on the open market here, on 31 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Fritz Frederick J.
Director
$174.20K (16)
+$174.20K
45,581
$71.30K
Tardugno Michael H
Executive Chairman of Board
$101.16K (7)
+$101.16K
100,321
$156.93K
Martinez Alberto R Jr
Director
$89.55K (10)
+$89.55K
45,000
$70.39K
Hooper Robert W
Director
$56.70K (3)
+$56.70K
25,687
$40.18K
+1,146%
Eylward Susan
General Counsel and Corp Sec
$38.15K (6)
−$38.15K
2,896
$4.53K
Braun Donald P
Director
$34.83K (2)
+$34.83K
15,499
$24.25K
Lindborg Stacy
President and CEO
$24.50K (1)
+$24.50K
106,358
$166.38K
CHURCH JEFFREY WAYNE
CFO
$9.45K (1)
+$9.45K
54,298
$84.94K
+2,263%
Le Goff Corinne
President and CEO
53,000
$82.91K
Faller Douglas Vincent
Chief Medical Officer
41,288
$64.59K
Dentzer James E
Director
21,897
$34.25K
+4,306%
Hazard Sebastien
Chief Medical Officer
20,000
$31.29K
Tumminello Timothy J
Controller
15,258
$23.87K
+1,913%
Pellizzari Christine A
Director
15,076
$23.58K
+4,374%
Kardaras Constantine John
Chief Accounting Officer
10,000
$15.64K
Voss Andreas
Director
6,607
$10.34K
+1,751%

No percentages here. This company's share count has moved by a factor of 6.7 over the window, from 2,192,353 to 14,620,732 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 240
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 637,644
History held since 8 Sep 2016